CN105481809A - Separation and purification method of salvianolic acid B and preparation method of salvianolic acid B magnesium salt - Google Patents

Separation and purification method of salvianolic acid B and preparation method of salvianolic acid B magnesium salt Download PDF

Info

Publication number
CN105481809A
CN105481809A CN201511017754.9A CN201511017754A CN105481809A CN 105481809 A CN105481809 A CN 105481809A CN 201511017754 A CN201511017754 A CN 201511017754A CN 105481809 A CN105481809 A CN 105481809A
Authority
CN
China
Prior art keywords
salvianolic acid
solution
extraction
mgcl
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201511017754.9A
Other languages
Chinese (zh)
Other versions
CN105481809B (en
Inventor
孙隆儒
张紫茹
张愉
陈奕名
季梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong University
Original Assignee
Shandong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong University filed Critical Shandong University
Priority to CN201511017754.9A priority Critical patent/CN105481809B/en
Publication of CN105481809A publication Critical patent/CN105481809A/en
Application granted granted Critical
Publication of CN105481809B publication Critical patent/CN105481809B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a separation and purification method of salvianolic acid B and a preparation method of a salvianolic acid B magnesium salt. The separation and purification method of the salvianolic acid B comprises taking a medicinal material of danshen root or white flower danshen as a raw material, and carrying out the steps of solvent extraction, separation and purification through a magnesium salt complexing method, MCI column purification, crystallization and recrystallization. According to the methods provided by the invention, a salvianolic acid B magnesium salt complexing method is adopted, so that a chromatography process with macroporous adsorption resin or polyamide column chromatography can be saved, the purification method is simpler and more time-saving, and the cost is lower. The preparation method of the salvianolic acid B magnesium salt is simple, and is low in cost, high in yield, and high in purity which can reach 98%, so that the preparation method is more suitable for mass production.

Description

A kind of separation purification method of salvianolic acid B and the preparation method of salvianolic acid B magnesium
Technical field
The present invention relates to a kind of from the extraction medicinal extract of the red sage root or Salvia miltiorrhiza f. medicinal material the method for separation and purification salvianolic acid B and the preparation method of its magnesium salts.
Background technology
Salviamiltiorrhizabung has promoting blood circulation to remove blood stasis, cool blood disappears carbuncle, the effect of the relieving restlessness that clears away heart-fire.Modern pharmacological research shows, red sage root energy coronary artery dilator, increase volume of blood flow, resist myocardial ischemia, improve microcirculation, reduce myocardial consumption of oxygen, improve heart function, hypotensive, reducing blood-fat, anticoagulation, antithrombotic, anti-oxidant, many effects such as to protect the liver.
Salvianolic acid B is one of red sage root primary water-soluble composition.Pharmacological research shows, salvianolic acid B has stronger pharmacological action in scavenging free radicals, protection cardiac-cerebral ischemia reperfusion injury and protection kidney etc.
Existing salvianolic acid B separation purification method is mainly separated by macroporous adsorbent resin or high speed adverse current chromatogram is separated.The main drawback that macroporous adsorbent resin is separated is wash-out length consuming time, and workload is large, and production cost is high.Chinese patent document CN1528756A (application number: 03151476.6) disclose a kind of processing method extracting salvianolic acid B from the red sage root, several method extracting salvianolic acid B from the red sage root is carried out organic assembling, have developed the novel process of a set of applicable separation and purification salvianolic acid B.Namely first extract with water, then use flocculate with chitosan, then carry out alcohol precipitation, then extract respectively by sherwood oil and ethyl acetate, finally adopt silica gel column chromatography to obtain the salvianolic acid B of higher degree.Aforesaid method adopts silica gel column chromatography separating purification salvianolic acid B, and the purity obtained is the salvianolic acid B of 50%-96%; But process is complicated, dead absorption is comparatively large, and operating process is loaded down with trivial details, is difficult to expand production to.XiaoWang etc. are at JournalofSeparationScience2007,30,3214-3217 describes the technique adopting high speed adverse current chromatogram separation and purification salvianolic acid B, and salvianolic acid B can be purified to 94.1% by display pH gradient adverse current chromatogram, and may be applied to life in enormous quantities; But the use of high-speed counter-current chromatograph has certain restriction.
Summary of the invention
For deficiency of the prior art, the invention provides a kind of from the red sage root or Salvia miltiorrhiza f. medicinal material the method for fast separating and purifying salvianolic acid B and the preparation method of salvianolic acid B magnesium, the method simple process, efficiency is high, and product purity can reach 98%.
Technical scheme of the present invention is as follows:
A separation purification method for salvianolic acid B, to comprise with the red sage root or Salvia miltiorrhiza f. medicinal material for raw material, through solvent extraction extraction, magnesium salts complexing seperation purifying, MCI column purification, crystallization and re-crystallization step, obtains salvianolic acid B;
Described solvent extraction extraction step is: by supersound extraction, filtration under the red sage root or Salvia miltiorrhiza f. medicinal material powder 70-80wt% ethanol room temperature, filtrate reduced in volume is obtained concentrated solution, concentrated solution adds aqueous suspension, with methylene dichloride or extraction into ethyl acetate removing impurity, discard methylene dichloride or ethyl acetate layer, water layer acidic solution adjusts pH=1 ~ 2, then is extracted with ethyl acetate, acetic acid ethyl acetate extract concentrating under reduced pressure, obtains salvianolic acid B crude extract.
According to the present invention, preferably, in solvent extraction extraction step: the quality of the red sage root or Salvia miltiorrhiza f. medicinal material powder and the volume ratio of 70-80wt% ethanol are 1:(8-12) g/mL; Acetic acid ethyl acetate extract is evaporated to medicinal extract shape, without ethanol taste.
According to the present invention, preferably, magnesium salts complexing seperation purification step is: by MgCl 2be dissolved in distilled water, be mixed with the MgCl that concentration is 0.01wt% ~ 1wt% 2the aqueous solution; By MgCl 2the aqueous solution joins in the salvianolic acid B crude extract of solvent extraction extraction step gained, stirred at ambient temperature, and dripping concentration is the NaHCO of 0.1wt% ~ 1wt% 3solution, after dropwising, continues stirring 1 ~ 2 minute; Add isopyknic methylene dichloride or extraction into ethyl acetate 2 times, the aqueous solution after extraction, adjust pH=1 ~ 2 with the hydrochloric acid of 1N ~ 2.5N, then with extraction into ethyl acetate 3 times, combined ethyl acetate extraction liquid, concentrating under reduced pressure;
This concentrated solution is repeated aforesaid operations, repurity 1 time, obtain salvianolic acid B sample after purifying.
According to the present invention, preferably, in magnesium salts complexing seperation purification step: described MgCl 2mgCl contained in solution 2mole number is 1/2nd of salvianolic acid B mole number in salvianolic acid B crude extract;
Preferably, described NaHCO 3naHCO contained in solution 3mole number equal salvianolic acid B mole number in salvianolic acid B crude extract, NaHCO used 3with MgCl 2mole ratio be 2:1.
According to the present invention, preferably, MCI column purification step is: by the salvianolic acid B sample after magnesium salts complexing seperation purifying, cross MCI pillar, the removal of impurity of 10wt%-20wt% methanol solution, 30wt%-60wt% methanol solution wash-out salvianolic acid B sample, concentrated salvianolic acid B sample eluent;
Salvianolic acid B sample eluent after concentrated is repeated above-mentioned MCI column purification step, the salvianolic acid B sample after must being further purified again.
According to the present invention, preferably, in MCI column purification step: described except using mixedly the preferred 20wt% methanol aqueous solution of elutriant; The preferred 30wt% methanol solution of described wash-out salvianolic acid B sample solution used.
According to the present invention, preferably, crystallization and re-crystallization step are: by MCI column purification step gained salvianolic acid B sample dissolution in methylene dichloride: methyl alcohol volume ratio=1:9 ~ 9:1, mixing solutions in carry out crystallization and recrystallization, obtain salvianolic acid B.
According to the present invention, preferably, in crystallization and re-crystallization step, described methylene dichloride: the volume ratio of methyl alcohol preferably (2 ~ 3): (8 ~ 7).
According to the present invention, a kind of preparation method of salvianolic acid B magnesium salt complex, step is as follows:
(1) preparation of magnesium hydroxide and Magnesium hydrogen carbonate:
Get MgCl 2be dissolved in distilled water, be mixed with the MgCl that concentration is 1wt% ~ 5wt% 2the aqueous solution, then drips the NaOH aqueous solution of 1wt% ~ 5wt%, and to not regeneration white precipitate, filtering-depositing, is precipitated to neutrality with distilled water wash; Get Mg (OH) 2be added to the water, pass into CO 260 ~ 90min clarifies to solution, and ultrasonic 10 ~ 20min removes unnecessary CO in solution 2, solution is crossed and is filtered insoluble particle, obtains magnesium bicarbonate solution; Magnesium bicarbonate solution must matching while using.
(2) preparation of salvianolic acid B magnesium salt complex:
The salvianolic acid B sample of above-mentioned preparation is added in magnesium bicarbonate solution, stirs and make it dissolve; With equal-volume methylene dichloride or extraction into ethyl acetate 2 times, except oil-soluble impurities, the water layer after extraction is concentrating under reduced pressure under 40 DEG C of conditions, and residual methylene dichloride or ethyl acetate in removing water layer, aqueous solution lyophilize, obtains salvianolic acid B magnesium salt complex.
According to the preparation method of salvianolic acid B magnesium salt complex of the present invention, preferably, in magnesium bicarbonate solution, the contained mole number of Magnesium hydrogen carbonate and the mole ratio of salvianolic acid B are 2:1.It is standby that magnesium bicarbonate solution used should be brand-new, matching while using.
According to the present invention, a kind of preparation method of salvianolic acid B magnesium salt complex, step is as follows:
Get MgCl 2be dissolved in distilled water, be mixed with the MgCl that concentration is 0.01wt% ~ 1wt% 2the aqueous solution; The salvianolic acid B of above-mentioned preparation is joined MgCl 2in the aqueous solution, stirring at room temperature, drips NaHCO 3the aqueous solution; After dropwising, suction filtration, lyophilize, obtains salvianolic acid B magnesium salt complex.
According to the preparation method of salvianolic acid B magnesium salt complex of the present invention, preferably, described MgCl 2mgCl contained in solution 2mole number and salvianolic acid B mole ratio are 1:2.Wherein, described NaHCO 3naHCO contained in solution 3mole number and salvianolic acid B mole ratio be 1:1.
Beneficial effect of the present invention:
The present invention adopts salvianolic acid B magnesium complexometry, can save the chromatography process of macroporous adsorbent resin or polyamide column chromatography, and purification process is simpler and save time, and cost is lower.The preparation method of salvianolic acid B magnesium is simple, and cost is low, and yield is high, and purity is high, and purity can reach 98%, is more suitable for large production.
Accompanying drawing explanation
Fig. 1 is the HPLC figure of the salvianolic acid B crude extract that the embodiment of the present invention 1 step (1) obtains.
Fig. 2 is the HPLC figure of the salvianolic acid B sample obtained after the embodiment of the present invention 1 step (2) magnesium salts complexometry purifying.
Fig. 3 is the HPLC figure of salvianolic acid B sample after the embodiment of the present invention 1 step (3) MCI purifying.
Fig. 4 is the HPLC figure of the salvianolic acid B obtained after the embodiment of the present invention 1 step (4) recrystallization.
Fig. 5 is the HPLC figure of the salvianolic acid B magnesium that the embodiment of the present invention 2 obtains.
Fig. 6 is the salvianolic acid B magnesium that obtains of the embodiment of the present invention 3 1h-NMR collection of illustrative plates.
Fig. 7 is the salvianolic acid B magnesium that obtains of the embodiment of the present invention 3 13c-NMR collection of illustrative plates.
Embodiment
Below by specific embodiment, also the invention will be further described by reference to the accompanying drawings, but be not limited thereto.
Embodiment 1: the preparation of high-purity danshinolic acid A
(1) extraction of salvianolic acid B: get red rooted salvia powder and be about 500g, add 75wt% ethanol, the quality of red rooted salvia powder and the volume ratio of ethanol are 1:12g/mL; Supersound extraction 2 times, each 30 minutes, filter, merging filtrate, concentrating under reduced pressure, concentrated solution adds suitable quantity of water, the removal of impurities of equal-volume dichloromethane extraction, water layer 2.5N hydrochloric acid adjusts pH=2, then with isopyknic extraction into ethyl acetate 2 times, acetic acid ethyl acetate extract concentrating under reduced pressure under 45 DEG C of conditions, obtains salvianolic acid B crude extract.
(2) magnesium salts complexometry purifying: by NaHCO 3with MgCl 2mol ratio is that the solution of 2:1 joins during salvianolic acid B slightly extracts, and makes it dissolve, 2 removal of impurities of isopyknic extraction into ethyl acetate, discard ethyl acetate layer, water layer acidic solution adjusts pH=2, then with equal-volume extraction into ethyl acetate 3 times, combined ethyl acetate extraction liquid, concentrating under reduced pressure, obtains concentrated solution;
Concentrated solution is repeated aforesaid operations, obtains the salvianolic acid B sample of purifying.
(3) MCI purifying: the salvianolic acid B sample of purifying in (2) is carried out the separation of MCI post, first with the removal of impurities of 20wt% methanol solution wash-out, then 30wt% methanol solution wash-out salvianolic acid B.
The salvianolic acid B elutriant eluted repeats a MCI post again and is separated, and obtains the salvianolic acid B sample that purity reaches 91%.
(4) recrystallization: by salvianolic acid B sample dissolution in step (3) in methyl alcohol: dissolve in the hot solution of methylene dichloride=3:8 (volume ratio), places crystallization.Leach crystallization, then carry out secondary crystal, obtain content of danshinolic acid B and reach 98%.
Embodiment 2: prepared by salvianolic acid B magnesium
Get MgCl 2be dissolved in distilled water, be mixed with the MgCl that concentration is 1wt% 2the aqueous solution, then drips the NaOH aqueous solution of 1wt%, and to not regeneration white precipitate, filtering-depositing, is precipitated to neutrality with distilled water wash; Get Mg (OH) 2be added to the water, pass into CO 260 ~ 90min clarifies to solution, and ultrasonic 10min removes unnecessary CO in solution 2, solution is crossed and is filtered insoluble particle, obtains magnesium bicarbonate solution; Magnesium bicarbonate solution must matching while using.
Join in freshly prepd magnesium bicarbonate solution by the salvianolic acid B sample 20mg of obtained for embodiment 1 98%, concussion makes it dissolve.With equal-volume extraction into ethyl acetate, combining extraction liquid, concentrating under reduced pressure evaporate to dryness, obtains high-purity danshinolic acid B magnesium salts.1H-NMR(600MHz,D 2O)δ:6.74(dd,J=29.3,13.8Hz,3H),6.67(t,J=9.4Hz,1H),6.62(dd,J=18.9,9.3Hz,2H),6.54(t,J=8.7Hz,2H),6.49(d,J=8.1Hz,1H),6.21(dd,J=31.4,8.0Hz,1H),6.07(s,1H),5.89(d,J=8.1Hz,1H),5.63(t,J=12.6Hz,1H),5.60–5.52(m,1H),4.78(dd,J=9.6,3.3Hz,1H),4.73–4.67(m,1H),3.91(d,J=4.5Hz,1H),2.89(dt,J=13.5,6.9Hz,1H),2.83–2.66(m,2H),2.38(dd,J=14.1,11.6Hz,1H).13C-NMR(151MHz,D 2O)δ:177.4,176.5,172.5,168.3,147.8,146.1,144.0,143.0,142.7,142.1,141.7,130.2,129.3,124.1,122.7,121.7,121.3,120.1,117.93,117.4,116.7,116.4,116.2,116.1,115.8,113.9,112.9,86.1,77.5,76.3,56.6,36.7,36.1.
Embodiment 3: prepared by salvianolic acid B magnesium
Get MgCl 2be dissolved in distilled water, be mixed with the MgCl that concentration is 0.05wt% 2the aqueous solution; 98% salvianolic acid B sample 20mg embodiment 1 prepared joins MgCl 2in the aqueous solution, stirring at room temperature, drips NaHCO 3the aqueous solution; After dropwising, suction filtration, lyophilize, obtains salvianolic acid B magnesium salt complex.
Described MgCl 2mgCl contained in solution 2mole number and salvianolic acid B mole ratio are 1:2.Wherein, described NaHCO 3naHCO contained in solution 3mole number and salvianolic acid B mole ratio be 1:1.

Claims (10)

1. a separation purification method for salvianolic acid B, to comprise with the red sage root or Salvia miltiorrhiza f. medicinal material for raw material, through solvent extraction extraction, magnesium salts complexing seperation purifying, MCI column purification, crystallization and re-crystallization step, obtains salvianolic acid B;
Described solvent extraction extraction step is: by supersound extraction, filtration under the red sage root or Salvia miltiorrhiza f. medicinal material powder 70-80wt% ethanol room temperature, filtrate reduced in volume is obtained concentrated solution, concentrated solution adds aqueous suspension, with methylene dichloride or extraction into ethyl acetate removing impurity, discard methylene dichloride or ethyl acetate layer, water layer acidic solution adjusts pH=1 ~ 2, then is extracted with ethyl acetate, acetic acid ethyl acetate extract concentrating under reduced pressure, obtains salvianolic acid B crude extract.
2. the separation purification method of salvianolic acid B according to claim 1, is characterized in that, in solvent extraction extraction step: the quality of the red sage root or Salvia miltiorrhiza f. medicinal material powder and the volume ratio of 70-80wt% ethanol are 1:(8-12) g/mL.
3. the separation purification method of salvianolic acid B according to claim 1, is characterized in that, magnesium salts complexing seperation purification step is: by MgCl 2be dissolved in distilled water, be mixed with the MgCl that concentration is 0.01wt% ~ 1wt% 2the aqueous solution; By MgCl 2the aqueous solution joins in the salvianolic acid B crude extract of solvent extraction extraction step gained, stirred at ambient temperature, and dripping concentration is the NaHCO of 0.1wt% ~ 1wt% 3solution, after dropwising, continues stirring 1 ~ 2 minute; Add isopyknic methylene dichloride or extraction into ethyl acetate 2 times, the aqueous solution after extraction, adjust pH=1 ~ 2 with the hydrochloric acid of 1N ~ 2.5N, then with extraction into ethyl acetate 3 times, combined ethyl acetate extraction liquid, concentrating under reduced pressure;
This concentrated solution is repeated aforesaid operations, repurity 1 time, obtain salvianolic acid B sample after purifying.
4. the separation purification method of salvianolic acid B according to claim 3, is characterized in that, in magnesium salts complexing seperation purification step: described MgCl 2mgCl contained in solution 2mole number is 1/2nd of salvianolic acid B mole number in salvianolic acid B crude extract;
Preferably, described NaHCO 3naHCO contained in solution 3mole number equal salvianolic acid B mole number in salvianolic acid B crude extract, NaHCO used 3with MgCl 2mole ratio be 2:1.
5. the separation purification method of salvianolic acid B according to claim 1, it is characterized in that, MCI column purification step is: by the salvianolic acid B sample after magnesium salts complexing seperation purifying, cross MCI pillar, the removal of impurity of 10wt%-20wt% methanol solution, 30wt%-60wt% methanol solution wash-out salvianolic acid B sample, concentrated salvianolic acid B sample eluent;
Salvianolic acid B sample eluent after concentrated is repeated above-mentioned MCI column purification step, the salvianolic acid B sample after must being further purified again.
6. the separation purification method of salvianolic acid B according to claim 5, is characterized in that, in MCI column purification step: described is 20wt% methanol aqueous solution except using mixedly elutriant; Described wash-out salvianolic acid B sample solution used is 30wt% methanol solution.
7. the separation purification method of salvianolic acid B according to claim 1, it is characterized in that, crystallization and re-crystallization step are: by MCI column purification step gained salvianolic acid B sample dissolution in methylene dichloride: carry out crystallization and recrystallization in the mixing solutions of methyl alcohol volume ratio=1:9 ~ 9:1, obtain salvianolic acid B.
8. the separation purification method of salvianolic acid B according to claim 7, is characterized in that, in crystallization and re-crystallization step, and described methylene dichloride: the volume ratio of methyl alcohol is (2 ~ 3): (8 ~ 7).
9. a preparation method for salvianolic acid B magnesium salt complex, step is as follows:
(1) preparation of magnesium hydroxide and Magnesium hydrogen carbonate:
Get MgCl 2be dissolved in distilled water, be mixed with the MgCl that concentration is 1wt% ~ 5wt% 2the aqueous solution, then drips the NaOH aqueous solution of 1wt% ~ 5wt%, and to not regeneration white precipitate, filtering-depositing, is precipitated to neutrality with distilled water wash; Get Mg (OH) 2be added to the water, pass into CO 260 ~ 90min clarifies to solution, and ultrasonic 10 ~ 20min removes unnecessary CO in solution 2, solution is crossed and is filtered insoluble particle, obtains magnesium bicarbonate solution; Magnesium bicarbonate solution must matching while using.
(2) preparation of salvianolic acid B magnesium salt complex:
Salvianolic acid B sample any one of claim 1-8 prepared adds in magnesium bicarbonate solution, stirs and makes it dissolve; With equal-volume methylene dichloride or extraction into ethyl acetate 2 times, except oil-soluble impurities, the water layer after extraction is concentrating under reduced pressure under 40 DEG C of conditions, and residual methylene dichloride or ethyl acetate in removing water layer, aqueous solution lyophilize, obtains salvianolic acid B magnesium salt complex.
10. a preparation method for salvianolic acid B magnesium salt complex, step is as follows:
Get MgCl 2be dissolved in distilled water, be mixed with the MgCl that concentration is 0.01wt% ~ 1wt% 2the aqueous solution; Salvianolic acid B prepared by any one of claim 1-8 is joined MgCl 2in the aqueous solution, stirring at room temperature, drips NaHCO 3the aqueous solution; After dropwising, suction filtration, lyophilize, obtains salvianolic acid B magnesium salt complex.
CN201511017754.9A 2015-12-29 2015-12-29 A kind of isolation and purification method of tanshin polyphenolic acid B and the preparation method of B magnesium tanphenolate Expired - Fee Related CN105481809B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201511017754.9A CN105481809B (en) 2015-12-29 2015-12-29 A kind of isolation and purification method of tanshin polyphenolic acid B and the preparation method of B magnesium tanphenolate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201511017754.9A CN105481809B (en) 2015-12-29 2015-12-29 A kind of isolation and purification method of tanshin polyphenolic acid B and the preparation method of B magnesium tanphenolate

Publications (2)

Publication Number Publication Date
CN105481809A true CN105481809A (en) 2016-04-13
CN105481809B CN105481809B (en) 2018-01-05

Family

ID=55669129

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201511017754.9A Expired - Fee Related CN105481809B (en) 2015-12-29 2015-12-29 A kind of isolation and purification method of tanshin polyphenolic acid B and the preparation method of B magnesium tanphenolate

Country Status (1)

Country Link
CN (1) CN105481809B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018137502A1 (en) * 2017-01-24 2018-08-02 浙江永宁药业股份有限公司 Crystal form of salvianolic acid a, and method for preparing same
CN117756890A (en) * 2024-01-03 2024-03-26 山东康耐斯生物科技有限公司 Preparation for repairing coliform by umbilical cord mesenchymal stem cells, preparation method thereof and application of preparation in weight losing

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1425659A (en) * 2002-12-31 2003-06-25 南京虹桥医药技术研究所 Process for preparing danshen salviandic acid
CN102432467A (en) * 2011-09-30 2012-05-02 吴谢军 Salvianolic acid A magnesium salt, preparation method and use of the salvianolic acid A magnesium salt, and salvianolic acid A magnesium salt-containing freeze-dried powder injection composition
CN104130226A (en) * 2014-04-01 2014-11-05 王平 Preparation method of high-content salvianolic acid B
CN104761520A (en) * 2015-04-10 2015-07-08 大连工业大学 Method for preparing high-purity salvianolic acid B employing salt precipitation
CN104974119A (en) * 2014-04-01 2015-10-14 中国科学院上海药物研究所 High-purity magnesium salvianolate B and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1425659A (en) * 2002-12-31 2003-06-25 南京虹桥医药技术研究所 Process for preparing danshen salviandic acid
CN102432467A (en) * 2011-09-30 2012-05-02 吴谢军 Salvianolic acid A magnesium salt, preparation method and use of the salvianolic acid A magnesium salt, and salvianolic acid A magnesium salt-containing freeze-dried powder injection composition
CN104130226A (en) * 2014-04-01 2014-11-05 王平 Preparation method of high-content salvianolic acid B
CN104974119A (en) * 2014-04-01 2015-10-14 中国科学院上海药物研究所 High-purity magnesium salvianolate B and preparation method thereof
CN104761520A (en) * 2015-04-10 2015-07-08 大连工业大学 Method for preparing high-purity salvianolic acid B employing salt precipitation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
段文强等: "ZnCl2沉淀法纯化丹酚酸B的工艺优选", 《中国实验方剂学杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018137502A1 (en) * 2017-01-24 2018-08-02 浙江永宁药业股份有限公司 Crystal form of salvianolic acid a, and method for preparing same
CN117756890A (en) * 2024-01-03 2024-03-26 山东康耐斯生物科技有限公司 Preparation for repairing coliform by umbilical cord mesenchymal stem cells, preparation method thereof and application of preparation in weight losing
CN117756890B (en) * 2024-01-03 2024-06-14 河北雄安重生生物科技有限公司 Preparation for repairing coliform by umbilical cord mesenchymal stem cells, preparation method thereof and application of preparation in weight losing

Also Published As

Publication number Publication date
CN105481809B (en) 2018-01-05

Similar Documents

Publication Publication Date Title
CN106008341B (en) A kind of purification process of benzene sulfonic acid along bent storehouse ammonium
CN102766185B (en) Method for respectively recovering ursodesoxycholic acid and chenodeoxycholic acid from ursodesoxycholic acid waste mother liquor
CN103467540A (en) Method for extracting salidroside from rhodiola
CN101891781A (en) Method for preparing high-purity gardenoside
CN102552340A (en) Preparation method of ginkgolide monomer and total ginkgo flavone-glycoide
CN104311620A (en) Method for purifying chenodeoxycholic acid
CN1257182C (en) Method for preparing enoxolone
CN106349324A (en) Method for extracting and separating maslinic acid from olive leaves
CN105481809A (en) Separation and purification method of salvianolic acid B and preparation method of salvianolic acid B magnesium salt
CN112266399B (en) High-purity separation and extraction method of epimedium extract
CN104119229A (en) Technology for producing pure chlorogenic acid
CN109369733A (en) A method of extracting a variety of flavone compounds simultaneously from leaf of Radix Et Rhizoma Fagopyri Tatarici
CN103087129B (en) Method for extracting geniposide from gardenia yellow pigment waste liquor
CN102199159B (en) Method for separating and purifying ginkgolide C in ginkgo root bark
CN104262362B (en) Vinblastine extraction and purification method
CN105523926B (en) A kind of extraction separation and purification method of salviandic acid A and the preparation method of salviandic acid A salt
CN103408539A (en) Production method of high-purity silibinin
CN105111144A (en) Method of extracting nuciferine from lotus leaves
CN104788509A (en) Process for extracting and preparing high-purity raffinose from degreased wheat germ
CN100402547C (en) Preparation method of high-content soybean saponin
CN102887909A (en) Method for extracting and separating ginkgolide B from ginkgo leaves
CN108210554B (en) Method for separating and purifying alcohol-soluble total flavonoids from liquorice
CN102875635A (en) Method for comprehensively extracting protodioscin and dioscin from dioscorea nipponica
CN106431877A (en) Method for preparing licochalcone from licorice residues
CN111018929A (en) Process for extracting and separating isocoryzanol

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180105

Termination date: 20211229